Stopped Haiti gained access to dolutegravir as first-line ART, so we cancelled the study before any patient was enrolled (we didn't want SOC group to receive EFV)
Conditions
HIV/AIDS
Interventions
DRUG: Elvitegravir, Cobicistat, TAF, FTC
DRUG: Efavirenz, TDF, and 3TC
Sponsor
Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic